Clinical Trial Update: Post-Operative Biomarker-Guided Precision Medicine For Cardiovascular Risk Reduction [EARLY_Phase 1]

View source ↗

Summary

An early-phase study evaluating biomarker-guided precision medicine to reduce cardiovascular risk after noncardiac surgery is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Injury After Noncardiac Surgery

Snippet

Sponsor: NYU Langone Health | Conditions: Myocardial Injury After Noncardiac Surgery | EARLY_Phase 1 | Status: RECRUITING